on Catheter Precision, Inc
Catheter Precision to Showcase at ISCAT 2024
Catheter Precision, Inc. (NYSE/American: VTAK) announced its participation at the 15th International Symposium on Catheter Ablation Techniques (ISCAT) in Paris, France, from October 16-18, 2024. This event, held biennially, addresses innovations in catheter ablation technologies, focusing on both atrial and ventricular arrhythmias.
The company aims to present its VIVO™ system at the symposium. VIVO™, a non-invasive 3D imaging system, aids in identifying ventricular arrhythmias' origins, enhancing procedural efficiency. It’s noteworthy that VIVO has already received FDA clearance and a CE mark.
David Jenkins, CEO, highlighted that attending such meetings is vital for their sales strategy, providing opportunities to engage with physicians and generate sales leads.
R. E.
Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all Catheter Precision, Inc news